Novartis AG Free Cash Flow 2010-2024 | NVS

Novartis AG free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • Novartis AG annual free cash flow for 2024 was $16.339B, a 19.83% increase from 2023.
  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.

Novartis AG Free Cash Flow 2010-2024 | NVS

  • Novartis AG annual free cash flow for 2024 was $16.339B, a 19.83% increase from 2023.
  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B